Role of phospholipases A2 in diabetic retinopathy: In vitro and in vivo studies

Biochemical Pharmacology

Volumn 86, Issue 11, 2013, Pages 1603-1613

  Lupo, Gabriella ^a   Motta, Carla ^a   Giurdanella, Giovanni ^a   Anfuso, Carmelina Daniela ^a   Alberghina, Mario ^a   Drago, Filippo ^a   Salomone, Salvatore ^a   Bucolo, Claudio ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Diabetes; Endothelial pericytes co culture, Cytokines; Phospholipases A2; Retina

Indexed keywords

GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; PHOSPHOLIPASE A2 INHIBITOR; STREPTOZOCIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD RETINA BARRIER; CELL PROLIFERATION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; MALE; MONOCULTURE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RAT; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; BOVINE; CELL LINE; CELL SURVIVAL; COCULTURE; COMPLICATION; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; CATTLE; DIABETES MELLITUS; DRUG EFFECT; ENDOTHELIAL/PERICYTES CO-CULTURE, CYTOKINES; PHOSPHOLIPASES A(2); RETINA;

ANIMALS; BLOOD-RETINAL BARRIER; CATTLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; COCULTURE TECHNIQUES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; GLUCOSE; MALE; MICROSCOPY, CONFOCAL; PERICYTES; PHOSPHOLIPASE A2 INHIBITORS; PHOSPHOLIPASES A2; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

DIABETES; ENDOTHELIAL/PERICYTES CO-CULTURE, CYTOKINES; PHOSPHOLIPASES A(2); RETINA;

EID: 84887454600     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.09.008     Document Type: Article

References (49)

1. N. Cheung, P. Mitchell, and T.Y. Wong Diabetic retinopathy Lancet 376 2010 124 136
2. E.A. Runkle, and D.A. Antonetti The blood-retinal barrier: structure and functional significance Methods Mol Biol 686 2011 133 148
3. E.A. Winkler, R.D. Bell, and B.V. Zlokovic Central nervous system pericytes in health and disease Nat Neurosci 14 2011 1398 1405
4. R. Motiejunaite, and A. Kazlauskas Pericytes and ocular diseases Exp Eye Res 86 2008 171 177
5. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
6. E.K. Vidro, S. Gee, R. Unda, J.X. Ma, and A. Tsin Glucose and TGFbeta2 modulate the viability of cultured human retinal pericytes and their VEGF release Curr Eye Res 33 2008 984 993
7. Y.W. Yun, M.H. Shin, Y.H. Lee, J.A. Rhee, and J.S. Choi Arterial stiffness is associated with diabetic retinopathy in Korean type 2 diabetic patients J Prev Med Public Health 44 6 2011 260 266
8. K.N. van Eijk, J.W. Blom, J. Gussekloo, B.C. Polak, and Y. Groeneveld Diabetic retinopathy screening in patients with diabetes mellitus in primary care: incentives and barriers to screening attendance Diabetes Res Clin Pract 96 2012 10 16
9. D. Kajdaniuk, B. Marek, W. Foltyn, and B. Kos-Kudła Vascular endothelial growth factor (VEGF) - Part 1: In physiology and pathophysiology Endokrynol Pol 62 2011 444 455
10. Z.K. Otrock, J.A. Makarem, and A.I. Shamseddine Vascular endothelial growth factor family of ligands and receptors: review Blood Cells Mol Dis 38 2007 258 268
11. A.N. Witmer, H.G. Blaauwgeers, H.A. Weich, K. Alitalo, G.F. Vrensen, and R.O. Schlingemann Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey Invest Ophthalmol Vis Sci 43 2002 849 857
12. J.F. Arevalo, J. Fromow-Guerra, H. Quiroz-Mercado, J.G. Sanchez, L. Wu, and M. Maia Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up Ophthalmology 114 2007 743 750
13. C. Starita, M. Patel, B. Katz, and A.P. Adamis Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (macugen) in diabetic retinopathy Dev Ophthalmol 39 2007 122 148
14. A.M. Joussen, V. Poulaki, N. Mitsiades, B. Kirchhof, K. Koizumi, and S. Döhmen A central role for inflammation in the pathogenesis of diabetic retinopathy FASEB J 16 2002 438 444
15. P.C. Lu, H. Ye, M. Maeda, and D.T. Azar Immunolocalization and gene expression of matrilysin during corneal wound healing Invest Ophthalmol Vis Sci 40 1 1999 20 27
16. A.M. Joussen, S. Doehmen, M.L. Le, K. Koizumi, S. Radetzky, and T.U. Krohne TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations Mol Vis 15 2009 1418 1428
17. M. Alberghina Phospholipase A(2): new lessons from endothelial cells Microvasc Res 80 2010 280 285
18. 2 in bovine retina capillary pericytes Biochim Biophys Acta 1686 2004 125 138
19. 2 by amyloid beta(25-35) peptide in bovine retina pericytes Biochim Biophys Acta 1733 2005 172 186
20. 2 downstream of the Src-phospholipase D1 (PLD1)-protein kinase C γ (PKCγ) signaling axis is required for hypoxia-induced pathological retinal angiogenesis J Biol Chem 286 2011 22489 22498
21. N.K. Singh, D.E Hansen 3rd, V. Kundumani-Sridharan, and G.N. Rao Both Kdr and Flt1 play a vital role in hypoxia-induced Src-PLD1-PKCγ-cPLA(2) activation and retinal neovascularization Blood 121 2013 1911 1923
22. 2 mediate glioma enhanced proangiogenic activity of brain endothelial cells Microvasc Res 81 2011 1 17
23. G. Lupo, C.D. Anfuso, N. Ragusa, R.P. Strosznajder, M. Walski, and M. Alberghina t-Butyl hydroperoxide and oxidized low density lipoprotein enhance phospholipid hydrolysis in lipopolysaccharide-stimulated retinal pericytes Biochim Biophys Acta 1531 2001 143 155
24. 2 protein expression through activation of PKCalpha and the MAPK/ERK cascade J Lipid Res 48 2007 782 793
25. J. Greenwood Characterization of a rat retinal endothelial cell culture and the expression of P-glycoprotein in brain and retinal endothelium in vitro J Neuroimmunol 39 1992 123 132
26. C. Bucolo, G.M. Leggio, F. Drago, and S. Salomone Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats Biochem Pharmacol 84 2012 88 92
27. N. Ferrara Vascular endothelial growth factor: basic science and clinical progress Endocr Rev 25 2004 581 611
28. J.I. Greenberg, D.J. Shields, S.G. Barillas, L.M. Acevedo, E. Murphy, and J. Huang A role for VEGF as a negative regulator of pericyte function and vessel maturation Nature 456 2008 809 813
29. J.L. Wilkinson-Berka Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide Curr Pharm Des 10 2004 3331 3348
30. S.D. Schoenberger, S.J. Kim, J. Sheng, K.A. Rezaei, M. Lalezary, and E. Cherney Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines Invest Ophthalmol Vis Sci 53 2012 5906 5911
31. S.P. Ayalasomayajula, A.C. Amrite, and U.B. Kompella Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas Eur J Pharmacol 13 498 2004 275 278
32. S.P. Ayalasomayajula, and U.B. Kompella Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model Eur J Pharmacol 458 2003 283 289
33. H. Gerhardt VEGF and endothelial guidance in angiogenic sprouting Organogenesis 4 2008 241 246
34. L. Jakobsson, C.A. Franco, K. Bentley, R.T. Collins, B. Ponsioen, and I.M. Aspalter Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting Nat Cell Biol 12 2010 943 953
35. S. Salomone, and C. Waeber Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects Front Pharmacol 2 2011 9
36. S.E. Yanni, G.W. Mc Collum, and J.S. Penn Genetic deletion of COX-2 diminishes VEGF production in mouse retinal Müller cells Exp Eye Res 91 1 2010 34 41
37. 2 in ocular homeostasis and diseases Biochimie 92 2010 611 619
38. 2 in the human eye: involvement in phagocytosis of photoreceptor outer segments Invest Ophthalmol Vis Sci 48 2007 1401 1409
39. T. Pannicke, I. Iandiev, A. Wurm, O. Uckermann, F. vom Hagen, and A. Reichenbach Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina Diabetes 55 2006 633 639
40. J.M. Barnett, G.W. McCollum, and J.S. Penn Role of cytosolic phospholipase A(2) in retinal neovascularization Invest Ophthalmol Vis Sci 51 2009 1136 1142
41. 2) Biochimie 95 2013 903 911
42. 2 in proliferation and migration of retinal pigment epithelium Curr Eye Res 37 2012 500 507
43. 2-{alpha} as a novel mechanism regulating endothelial cell cycle-progression and angiogenesis J Biol Chem 284 2009 5784 5796
44. 2 mediates endothelial cell S phase progression J Biol Chem 281 2006 35709 35716
45. O. Gallo, A. Franchi, L. Magnelli, I. Sardi, A. Vannacci, and V. Boddi Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer: implications for tumor angiogenesis and metastasis Neoplasia 3 2001 53 61
46. 2 as a mediator of disease pathogenesis Cell Microbiol 12 2010 1369 1377
47. 2 activity Mol Vis 10 2004 341 350
48. J. Adamiec-Mroczek, and J. Oficjalska-Młyńczak Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes - role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy Graefes Arch Clin Exp Ophthalmol 246 2008 1665 1670
49. L.M. Aiello, and J. Cavallerano Diabetic retinopathy Curr Ther Endocrinol Metabol 5 1994 436 446